4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Orally administered tetracycline for phlyctenular keratoconjunctivitis.

      American Journal of Ophthalmology
      Administration, Oral, Administration, Topical, Adolescent, Anti-Bacterial Agents, therapeutic use, Anti-Inflammatory Agents, Child, Humans, Keratoconjunctivitis, diagnosis, drug therapy, Male, Prednisolone, Recurrence, Tetracycline

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We treated six patients who had recurrent episodes of nontuberculous phlyctenular keratoconjunctivitis and progressive corneal vascularization and scarring with oral tetracycline. This treatment resulted in rapid relief of symptoms and the apparent arrest of this disease. There have been no complications secondary to the use of tetracycline. To date, there has been only one recurrence in the patients treated with tetracycline which consisted of mild conjunctival hyperemia. We believe oral tetracycline is a safe and effective treatment for resistant and recurrent nontuberculous phlyctenular keratoconjunctivitis and an alternative to topical corticosteroid treatment in those patients suffering from corticosteroid-induced complications.

          Related collections

          Author and article information

          Comments

          Comment on this article